Veracyte, Inc. is an American biotechnology company specializing in diagnostics and predictive testing using advanced genomic technologies. The company develops and commercializes tests for the diagnosis and monitoring of various types of cancer and other diseases, such as lung cancer, thyroid cancer, and pulmonary fibrosis. Veracyte focuses on improving diagnostic accuracy and personalizing treatment for patients through non-invasive tests that assist healthcare providers in selecting the most appropriate therapeutic approach.